Organization
Department of Early Drug Development Center, Peking University Cancer Hospital & Institute, Beijing, China
1 abstract
Abstract
SI-B003 (PD-1/CTLA-4) in patients with advanced solid tumors: A phase I study.Org: Department of Early Drug Development Center, Peking University Cancer Hospital & Institute, Beijing, China, Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China, Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China, Henan Cancer Hospital, Zhengzhou, China, Shanghai General Hospital, Shanghai, China,